Skip to content

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

Home
Pharma applications
Non-pharma applications
CD derivatives
Events
E-ducation

Tag: S-protein

March 12, 2021 Drug delivery / Pharma applications

An interesting hypothesis: CD‐sACE2 inclusion compounds to treat COVID‐19

Angiotensin‐converting enzyme 2 (ACE2) has been identified as the main receptors for SARS‐CoV and SARS‐CoV‐2. Soluble ACE2 (sACE2) can bind

Continue reading

Search for:

Recent Posts

Comparative Study of Nanosuspensions for Acetogenins Delivery
Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
Events of American Cyclodextrin Consortium
Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
Nano-Enabled Toxicity of Pharmaceutical Excipients

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

LinkedIn
X
Facebook

Categories

Agriculture (27)
Analysis (66)
CD as API (347)
CD derivatives (410)
Cosmetics and toilettry (51)
Diagnosis (12)
Drug delivery (791)
E-ducation (63)
Environmental (134)
Events (234)
Food (222)
Gene delivery (20)
Household products (1)
Household products (4)
In Hungarian (4)
Life sciences (42)
Non-pharma applications (400)
Other industrial use (106)
Pharma applications (1,183)
Supramolecular systems (40)
Uncategorized (146)

Top Posts

Comparative Study of Nanosuspensions for Acetogenins Delivery
Polyphenols' encapsulation in cyclodextrins: An updated systematic literature review
Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
Harnessing Organoid Platforms for Nanoparticle Drug Development
A sugammadex-analogue, per-6-O-carboxyhexyl-thio-gamma-CD (OKL-1111) is a highly potent and universal reversal agent for anticoagulants
New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
Postponed to August 5-7: 10th Annual Congress of Nano Science and Technology-2020 (Nano S&T-2020)
Special Issue "Cyclodextrin Chemistry and Toxicology II"

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 4,473 other subscribers

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website